Healthcare is rarely one-size-fits-all. Every patient brings a different medical history, treatment plan, medication experience, and set of individual considerations to the conversation with their healthcare provider.
In certain circumstances, compounded medications can serve an important medical need for patients whose needs cannot be met by an FDA-approved medication.¹ For healthcare providers who prescribe compounded medications—or are interested in better understanding patient-specific compounding—knowing the relationship between the provider, the prescription, and the compounding pharmacy can provide helpful context for how these medications move from prescription to patient.
What Makes a Compounded Prescription Patient-Specific?
Under Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act), compounding is based on the receipt of a valid prescription for an identified individual patient, with limited provisions for anticipatory compounding.²
As a 503A compounding pharmacy, WP Pharma Labs prepares compounded medications pursuant to prescriptions written for identified individual patients.
The healthcare provider remains at the center of the prescribing decision. After evaluating the patient, the provider determines whether a compounded medication is appropriate and establishes the prescription based on the individual patient’s needs.
Depending on the prescription, this may include a particular active ingredient or combination of ingredients, strength or concentration, dosage form, quantity, and directions for use.
This patient-specific prescription requirement is an important distinction within the 503A compounding framework.²
The Provider’s Role Comes First
Before a patient-specific compounded prescription reaches the pharmacy, the healthcare provider evaluates the patient and determines the appropriate course of treatment.
That evaluation may take into consideration factors such as the patient’s medical history, current medications, treatment plan, previous therapies, allergies or sensitivities, and other relevant clinical information.
FDA notes that compounded medications may address certain patient needs when an FDA-approved medication cannot meet those needs—for example, when a patient requires a medication without a particular ingredient because of an allergy or needs a different dosage form.¹
When the provider determines that a patient-specific compounded medication is appropriate, the prescription communicates the formulation and prescribing information to the compounding pharmacy.
The pharmacy’s role is then to prepare the prescribed formulation in accordance with the prescription and applicable compounding requirements.
What Happens After the Pharmacy Receives the Prescription?
Once WP Pharma Labs receives a patient-specific prescription, it moves through the pharmacy’s established review and processing procedures.
Patient and prescription information is reviewed as part of that process. When clarification regarding a prescription is necessary, communication may occur between the pharmacy and the prescribing healthcare professional before proceeding.
The medication is then prepared according to the patient-specific prescription and, following applicable pharmacy processes, dispensed for the individual patient identified on that prescription.
While the journey from prescription to dispensing involves several pharmacy processes, the foundation remains the same: the prescription reflects the provider’s independent clinical decision for an individual patient.
Individualized Prescriptions Can Take Different Forms
Depending on the patient-specific prescription, compounded preparations may involve different strengths, ingredients, or dosage forms.
Within the WP Pharma Labs portfolio, compounded preparations may include capsules, creams and other topical preparations, sublingual preparations, injectables, pellets, and other compounded dosage forms.
USP maintains standards related to pharmaceutical compounding, including standards addressing nonsterile preparations under USP <795> and sterile preparations under USP <797>.³ These standards are part of the broader framework surrounding pharmacy compounding practices.
WP Pharma Labs maintains patient-specific compounded formulations across several areas of practice, including men’s and women’s health, hormone therapy, sexual health, dermatology, and longevity.
The Provider-Pharmacy Relationship
Patient-specific compounding brings together two distinct roles.
The healthcare provider evaluates the individual patient, determines whether a compounded medication is appropriate, and establishes the prescription. The compounding pharmacy receives that prescription and prepares the medication according to the prescribed formulation and applicable compounding requirements.
Understanding those roles can help healthcare professionals better understand where 503A compounding fits within the broader patient care process.
For providers, it also reinforces an important distinction: under Section 503A, compounding is centered on prescriptions for identified individual patients.²
An Important Distinction About Compounded Medications
Compounded medications are not FDA-approved. This means FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed in the same manner as FDA-approved drugs.⁴
For healthcare professionals, understanding this distinction—as well as the regulatory framework surrounding patient-specific compounding—is an important part of evaluating compounded medications within an individual patient’s treatment plan.
Explore Patient-Specific Compounding with WP Pharma Labs
WP Pharma Labs works with healthcare professionals and offers a portfolio of patient-specific compounded formulations across multiple areas of practice.
Healthcare professionals can explore the WP Pharma Labs portfolio to review available formulations and dosage forms or contact WP Pharma Labs for additional information about available formulations and the prescription process.
References
- U.S. Food and Drug Administration. Consumer and Health Care Professional Information – Human Drug Compounding. FDA. https://www.fda.gov/drugs/human-drug-compounding/consumer-and-health-care-professional-information
- U.S. Food and Drug Administration. Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. FDA. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/prescription-requirement-under-section-503a-federal-food-drug-and-cosmetic-act-guidance-industry
- United States Pharmacopeia. USP Quality Standards for Compounding. USP. https://www.usp.org/compounding
- U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. FDA. https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
Not FDA-reviewed or approved. Compounded for patient-specific use only.